Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
5 drugs in development
By Therapeutic Area
top 6
R&D Momentum
62/100
Pipeline Velocity
27/100
Trial Completion Rate
77/100
Pipeline Concentration
16/100
Pipeline Freshness
51/100
Strategic Signals
Activity
Last 14 days
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome-a Stepped Wedge Cluster Randomized Evaluation in the SWEDEHEART-registry
Transducer Levelling Errors in Everyday ICU Practice - A Multicentre Blinded Observational Study
Randomized Cross-over Trial in Patients Treated With Both Insulin & Hydrocortisone
A Person-centered, Theory-based, Intervention to Enhance Adolescents' Motivation for Adequate Oral Hygiene Behavior - Method Development Through the Integration of Digital Technology.
Swedish Evaluation of Left Ventricular Assist Device
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)